Clinical Trial Update: Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hypersensitivity to female sex hormones in women with unexplained recurrent pregnancy loss. The trial status is currently unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Snippet

Sponsor: EVE Medical Systems Ltd. | Conditions: Abortion, Recurrent | Phase 2 | Status: UNKNOWN